Cencora (COR) Shareholders Approve All Proposals at 2026 Annual Meeting
Cencora, Inc.
Subscribe to track COR
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Cencora (COR) Shareholders Approve All Proposals at 2026 Annual Meeting
Company: Cencora, Inc. (COR) Form: 8-K | Filed: 2026/03/06 Significance: Low
Event: Submission of Matters to a Vote of Security Holders
Meeting Results (March 5, 2026): • Directors: All 11 nominees elected to the board. • Compensation: Advisory vote on executive compensation approved. • Auditors: Appointment of Ernst & Young LLP ratified.
Key Insight: Routine annual meeting with all board recommendations approved by shareholders. No contested items reported.
Market Context: Cencora is a large-cap healthcare solutions company ($72.39B Market Cap).
Comprehensive Analysis
SEC Filing Analysis: Cencora, Inc. (COR)
Executive Summary
- Trading Significance: Low
- Key Takeaway: Shareholders approved all board proposals, including director elections and executive compensation, at the 2026 Annual Meeting.
- Market Impact: Neutral - Routine corporate governance event.
Company Information
| Field | Value |
|---|---|
| Company | Cencora, Inc. |
| Ticker Symbol | COR |
| CIK | 0001140859 |
| Industry | Wholesale-Drugs Proprietaries & Druggists' Sundries |
| Market Cap | $72.39 Billion |
Filing Details
Form 8-K: Submission of Matters to a Vote of Security Holders
The company held its 2026 Annual Meeting of Shareholders on March 5, 2026. The following matters were voted upon:
Voting Results
- Election of Directors: All 11 nominees were elected to serve as directors. Votes 'For' ranged from approx. 163M to 168M out of ~194.5M shares outstanding.
- Executive Compensation: Shareholders approved, on an advisory basis, the compensation of named executive officers (Say-on-Pay) with ~156.8M votes For and ~11.4M Against.
- Auditor Ratification: The appointment of Ernst & Young LLP for fiscal 2026 was ratified with ~165.7M votes For.
Market Impact Analysis
- Stock Impact Prediction: Neutral. The results align with board recommendations and represent standard corporate governance procedure.
- Sentiment Indicator: Neutral. No contentious items, failed votes, or significant shareholder dissent were reported in the filing.
(Note: Investment Insights section omitted due to Low Significance classification)
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.